Main > PSYCHIATRY > Pediatrics > Attention Deficit HyperAc. Disorder > Treatment > Central Nervous System Stimulants > Amphetamine. > Co.: USA. N (Phase III/Patent)

---

Co.: USA. N (Phase III/Patent)'s subsections
Company
Conditionally Bioreversible Deriv.
L-Lysine-d-Amphetamine Conj.
Name (Not RTM.)
Patent
UpDate: 12.06.2005
Web-Site

Co.: USA. N (Phase III/Patent)'s products
This section has no products